BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1808 related articles for article (PubMed ID: 26319069)

  • 1. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
    Moliva JI; Turner J; Torrelles JB
    Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-Generation Vaccines Based on Bacille Calmette-Guérin.
    Nieuwenhuizen NE; Kaufmann SHE
    Front Immunol; 2018; 9():121. PubMed ID: 29459859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Mycobacterium bovis Calmette et Guérin (BCG) in oncotherapy: Bladder cancer and beyond.
    Mukherjee N; Julián E; Torrelles JB; Svatek RS
    Vaccine; 2021 Dec; 39(50):7332-7340. PubMed ID: 34627626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis vaccines: beyond bacille Calmette-Guerin.
    McShane H
    Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2782-9. PubMed ID: 21893541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraduodenal vaccination of brushtail possums with bacille Calmette-Guérin enhances immune responses and protection against Mycobacterium bovis infection.
    Buddle BM; Aldwell FE; Keen DL; Parlane NA; Yates G; de Lisle GW
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):377-83. PubMed ID: 9432396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
    Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis.
    Gengenbacher M; Nieuwenhuizen N; Vogelzang A; Liu H; Kaiser P; Schuerer S; Lazar D; Wagner I; Mollenkopf HJ; Kaufmann SH
    mBio; 2016 May; 7(3):. PubMed ID: 27222470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCG - old workhorse, new skills.
    Gengenbacher M; Nieuwenhuizen NE; Kaufmann S
    Curr Opin Immunol; 2017 Aug; 47():8-16. PubMed ID: 28719821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Veterinary tuberculosis vaccine development.
    Griffin JF
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S223-8. PubMed ID: 10875788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manipulation of BCG vaccine: a double-edged sword.
    Singh VK; Srivastava R; Srivastava BS
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):535-43. PubMed ID: 26810060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCG vaccination against tuberculosis in European badgers (Meles meles): a review.
    Robinson PA; Corner LA; Courcier EA; McNair J; Artois M; Menzies FD; Abernethy DA
    Comp Immunol Microbiol Infect Dis; 2012 Jul; 35(4):277-87. PubMed ID: 22340983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis.
    Clark S; Cross ML; Smith A; Court P; Vipond J; Nadian A; Hewinson RG; Batchelor HK; Perrie Y; Williams A; Aldwell FE; Chambers MA
    Vaccine; 2008 Oct; 26(46):5791-7. PubMed ID: 18789366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained protection against tuberculosis conferred to a wildlife host by single dose oral vaccination.
    Tompkins DM; Buddle BM; Whitford J; Cross ML; Yates GF; Lambeth MR; Nugent G
    Vaccine; 2013 Jan; 31(6):893-9. PubMed ID: 23246543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection.
    Thom M; Howard C; Villarreal-Ramos B; Mead E; Vordermeier M; Hope J
    Tuberculosis (Edinb); 2008 Jul; 88(4):324-34. PubMed ID: 18329343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against
    Moliva JI; Turner J; Torrelles JB
    Front Immunol; 2017; 8():407. PubMed ID: 28424703
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel vaccination approaches to prevent tuberculosis in children.
    Triccas JA; Counoupas C
    Pneumonia (Nathan); 2016; 8():18. PubMed ID: 28702297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 91.